---
audienceLevel: patient
cancerTypes:
- skin
- kidney
- bladder
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Avelumab - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/avelumab
version: v1
---

# Avelumab - NCI

# Avelumab

Placeholder slot

(a-VEL-yoo-mab)

Avelumab is a type of drug called an immune checkpoint inhibitor. It works by binding to the protein PD-L1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This allows the immune system to attack the cancer cells.

US Brand Name(s)

Bavencio

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cd725a1-2fa4-408a-a651-57a7b84b2118&audience=consumer)

## Use in Cancer

Avelumab
is approved to treat:

- **[Merkel cell carcinoma](/Common/PopUps/popDefinition.aspx?id=658511&version=Patient&language=English)** (a type of [skin cancer](/Common/PopUps/popDefinition.aspx?id=445084&version=Patient&language=English)) that has spread. It is used in adults and in children aged 12 years and older.
- **[Renal cell carcinoma](/Common/PopUps/popDefinition.aspx?id=661352&version=Patient&language=English)** (a type of [kidney cancer](/Common/PopUps/popDefinition.aspx?id=444995&version=Patient&language=English)) that has spread or cannot be removed by surgery. It is used with [axitinib](/Common/PopUps/popDefinition.aspx?id=538635&version=Patient&language=English) as the first treatment.
- **[Urothelial cancer](/Common/PopUps/popDefinition.aspx?id=783188&version=Patient&language=English)** (a type of cancer in the [bladder](/Common/PopUps/popDefinition.aspx?id=46501&version=Patient&language=English) or [urinary tract](/Common/PopUps/popDefinition.aspx?id=46095&version=Patient&language=English)) that has spread or cannot be removed by surgery. It is used:
- As [maintenance therapy](/Common/PopUps/popDefinition.aspx?id=45768&version=Patient&language=English) in patients whose cancer did not get worse after first-line [platinum](/Common/PopUps/popDefinition.aspx?id=45841&version=Patient&language=English) chemotherapy.
- In patients whose cancer got worse during or after treatment with platinum chemotherapy.

Avelumab
is also being studied in the treatment of other types of
cancer.

## More About Avelumab

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745752) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Avelumab](https://medlineplus.gov/druginfo/meds/a617006.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder Cancer Effects](https://www.cancer.gov/news-events/cancer-currents-blog/2023/bladder-cancer-padcev-keytruda-doubles-survival)

[Study Identifies a Potential Cause of Immunotherapy’s Heart-Related Side Effects](https://www.cancer.gov/news-events/cancer-currents-blog/2022/immunotherapy-myocarditis-cause)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Cancer Immunotherapies Don’t Work for Everyone: HLA Gene May Explain Why](https://www.cancer.gov/news-events/cancer-currents-blog/2022/immunotherapy-cancer-biomarker-hla-gene)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

[Immune Checkpoint Inhibitors](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Avelumab](https://www.cancer.gov/research/participate/clinical-trials/intervention/C116870) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
